Namitecan: a hydrophilic camptothecin with a promising preclinical profile.
about
Integrative population pharmacokinetic and pharmacodynamic dose finding approach of the new camptothecin compound namitecan (ST1968).Phase-I dose finding and pharmacokinetic study of the novel hydrophilic camptothecin ST-1968 (namitecan) in patients with solid tumors.Strategies for the Optimization of Natural Leads to Anticancer Drugs or Drug Candidates.An overview of quinoline as a privileged scaffold in cancer drug discovery.Semisynthesis, cytotoxic activity, and oral availability of new lipophilic 9-substituted camptothecin derivatives.Silicon-containing analogs of camptothecin as anticancer agents.
P2860
Namitecan: a hydrophilic camptothecin with a promising preclinical profile.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Namitecan: a hydrophilic camptothecin with a promising preclinical profile.
@en
type
label
Namitecan: a hydrophilic camptothecin with a promising preclinical profile.
@en
prefLabel
Namitecan: a hydrophilic camptothecin with a promising preclinical profile.
@en
P2093
P1476
Namitecan: a hydrophilic camptothecin with a promising preclinical profile.
@en
P2093
G L Beretta
M De Cesare
N Zaffaroni
P304
P356
10.2174/092986712801323252
P577
2012-01-01T00:00:00Z